Spinocerebellar Ataxia Type 31 Exacerbated by Anti-amino Terminal of Alpha-enolase Autoantibodies

We herein report a 61-year-old woman who was genetically diagnosed with spinocerebellar ataxia type 31 whose symptoms were modified by anti-amino terminal of alpha-enolase (NAE) antibodies, known as a biomarker of Hashimoto's encephalopathy (HE), and ultimately responded to immunotherapy. The r...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeniya, Satoshi, Sanjo, Nobuo, Kuwahara, Hiroya, Ishikawa, Kinya, Higashi, Miwa, Matsunaga, Akiko, Yoneda, Makoto, Mizusawa, Hidehiro, Yokota, Takanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556240/
https://www.ncbi.nlm.nih.gov/pubmed/36104177
http://dx.doi.org/10.2169/internalmedicine.8883-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556240/
https://www.ncbi.nlm.nih.gov/pubmed/36104177
http://dx.doi.org/10.2169/internalmedicine.8883-21

Ejemplares similares